SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $288.15 million. The enterprise value is $306.52 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.56 million shares outstanding. The number of shares has increased by 132.22% in one year.
| Current Share Class | 8.56M |
| Shares Outstanding | 8.56M |
| Shares Change (YoY) | +132.22% |
| Shares Change (QoQ) | +1.59% |
| Owned by Insiders (%) | 6.79% |
| Owned by Institutions (%) | 5.21% |
| Float | 4.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.42 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.47 |
| EV / EBITDA | 35.35 |
| EV / EBIT | 41.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40
| Current Ratio | 0.40 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.07 |
| Debt / FCF | n/a |
| Interest Coverage | 0.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 17.20% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -45.41% |
| Revenue Per Employee | $786,739 |
| Profits Per Employee | -$706,957 |
| Employee Count | 46 |
| Asset Turnover | 1.34 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, SANUWAVE Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +428.31% in the last 52 weeks. The beta is 1.20, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +428.31% |
| 50-Day Moving Average | 29.71 |
| 200-Day Moving Average | 23.75 |
| Relative Strength Index (RSI) | 61.64 |
| Average Volume (20 Days) | 90,857 |
Short Selling Information
The latest short interest is 48,021, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 48,021 |
| Short Previous Month | 13,631 |
| Short % of Shares Out | 0.56% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 1.03 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $36.19 million and -$32.52 million in losses. Loss per share was -$5.58.
| Revenue | 36.19M |
| Gross Profit | 27.73M |
| Operating Income | 7.45M |
| Pretax Income | n/a |
| Net Income | -32.52M |
| EBITDA | 8.67M |
| EBIT | 7.45M |
| Loss Per Share | -$5.58 |
Full Income StatementBalance Sheet
The company has $8.50 million in cash and $26.87 million in debt, giving a net cash position of -$18.37 million or -$2.15 per share.
| Cash & Cash Equivalents | 8.50M |
| Total Debt | 26.87M |
| Net Cash | -18.37M |
| Net Cash Per Share | -$2.15 |
| Equity (Book Value) | -17.29M |
| Book Value Per Share | -2.02 |
| Working Capital | -28.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$162,000 and capital expenditures -$538,000, giving a free cash flow of -$700,000.
| Operating Cash Flow | -162,000 |
| Capital Expenditures | -538,000 |
| Free Cash Flow | -700,000 |
| FCF Per Share | -$0.08 |
Full Cash Flow StatementMargins
Gross margin is 76.63%, with operating and profit margins of 20.59% and -89.86%.
| Gross Margin | 76.63% |
| Operating Margin | 20.59% |
| Pretax Margin | -89.78% |
| Profit Margin | -89.86% |
| EBITDA Margin | 23.96% |
| EBIT Margin | 20.59% |
| FCF Margin | n/a |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -132.22% |
| Shareholder Yield | -132.22% |
| Earnings Yield | -11.29% |
| FCF Yield | -0.24% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 0.0026667:1.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0026667:1 |
Scores
SANUWAVE Health has an Altman Z-Score of -9.46 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.46 |
| Piotroski F-Score | 5 |